
The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …

NICE has announced its evidence-based recommendation that Kyowa Kirin International’s Crysvita (burosumab) be made available on the NHS for the …

The National Institute for Health Research (NIHR) has released a new whitepaper outlining the substantial benefits NHS High Throughput Centres …

As September came to a close and October began the UK was hit hard in the headlines after American firm …

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …

Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the …

The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population …

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …

A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the …